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GenotypeHuman Parechovirus (HPeV), a member of the Picornaviridae family, is an infectious agent mostly affecting
children. There are 16 recognized genotypes which have globally spread. This study incorporated a total of
2957 nasopharyngeal (NP) swab and 759 fecal samples that were collected from different parts of Thailand.
The NP of HPeV was detected in 0.4% of NP swab and 6.1% of fecal samples. The majority of HPeV infections
occur in infants below the age of 2 years, while infections were detected in children above the age of 10 years
as well. Various genotypes comprising 1A, 1B, 2, 3, 4, 5, 6, 10 and 14 have been characterized. This study
revealed recombination events in 16 samples in which HPeV1B was shown as the highest frequency. In
conclusion, HPeV can be detected in both the respiratory and GI tract. Moreover, HPeV which circulates in
Thailand is highly diverse and subject to recombination.inical Virology, Department of
ity, Bangkok 10330, Thailand.
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rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Human parechovirus (HPeV) is a small non-enveloped single
stranded RNA virus of positive polarity which belongs to the vast fam-
ily, Picornaviridae. The virus has ﬁrst been discovered from an out-
break of diarrhea among children in 1961. Based on their serology
and clinical presentation, the virus was deﬁned as echovirus 22 and
23 of the genus Enterovirus (Wigand and Sabin, 1961). However,
studies on genetics, protein translation and biological properties of
the virus have shown that it is different from other members of the
genus Enterovirus. Hence, it has been reclassiﬁed into a new genus,
Parechovirus and those viruses previously deﬁned as echovirus 22
and 23 were re-named HPeV1 and HPeV2, respectively (Stanway
and Hyypia, 1999; Stanway et al., 1994). Recently, additional types of
HPeV have been reported, whichwere associated with different clinical
manifestations. For example, HPeV3 was isolated from nasopharyngeal
aspirates (NPA) and related to sepsis in neonates (Ito et al., 2004).
HPeV4 was isolated from fecal samples and related to fever in neonates
(Benschop et al., 2006a). HPeV5 had previously been deﬁned as HPeV2
based on serology of children presenting with high fever but upon
genome analysis was re-classiﬁed as type ﬁve (Oberste et al., 1998).
HPeV6 was isolated from one child suffering from Reye's syndrome
(Watanabe et al., 2007), HPeV7was identiﬁed bymetagenomicmethodin fecal samples of a healthy child (Li et al., 2009), HPeV8 was isolated
from fecal samples during an outbreak of acute diarrhea in Brazil
(Drexler et al., 2009), and HPeV9 to HPeV16 which unpublished but
had already been assigned by the following website (http://www.
picornastudygroup.com/types/parechovirus/hpev.html).
Since the ﬁrst report of HPeV infection, the epidemics of virus have
been continuously reported. The most common genotype of the virus
that could be isolated worldwide was HPeV1B followed by HPeV3. In
contrast, other genotypes such as HPeV1A, HPeV2, and HPeV4-6 were
less common among infected patients than those two dominant geno-
types (Benschop et al., 2008b; Ito et al., 2010; Pham et al., 2010; Tapia
et al., 2008). It should be noted that HPeV7 to 16 are a new genotypes
that have been recently discovered. Thus, epidemiology and prevalence
of these genotypes have not been fully established. The virus wasmostly
detected in children especially in infants below the age of 3 years
(Benschop et al., 2006b; Tauriainen et al., 2007; Verboon-Maciolek
et al., 2005). However, patients above the age of 10 years have also
been noted (Abed and Boivin, 2006; Figueroa et al., 1989; Tapia et al.,
2008; Watanabe et al., 2007). The longitudinal surveillance in USA be-
tween 1983 and 2005 has shown 3% of HPeV1 and 68% of HPeV2 had
been isolated from infants less than 1 year old (Khetsuriani et al., 2006).
In contrast, a study conducted in the Netherlands in 2000 has proposed
that children below the age of 3 years were infected with HPeV1 and
HPeV3 (Benschop et al., 2006b). The clinical presentations of HPeV infec-
tionwere associatedwithmild disease of the respiratory and gastrointes-
tinal (GI) tract (Harvala et al., 2008; Zhang et al., 2010; Zhong et al., 2011).
According to a recent study, HPeV, especially HPeV3, was strongly associ-
ated with sepsis in neonates (Boivin et al., 2005; Harvala et al., 2009).
160 T. Chieochansin et al. / Virology 421 (2011) 159–166The HPeV genome comprises approximately 7300 nucleotides
ﬂanked by an un-translated region (UTR) at both the 5′ and 3′ end.
The virus translates a polyprotein with one single open reading
frame (ORF) which is subsequently cleaved during the post-transla-
tional process into 3 structural proteins, VP0, VP3 and VP1, and 7
non-structural proteins, 2A–2C and 3A–3D (Harvala and Simmonds,
2009; Harvala et al., 2010).
Based on differences in antigenicity along with vast diversities in
the virus genome, 16 types of HPeV have been classiﬁed (http://
www.picornastudygroup.com/types/parechovirus/hpev.html). Rapid
changes in their genomes normally occurring in the course of theTable 1
Summary of HPeV positive samples.
Samples code Samples type Age Sex
CU-B402 Fecal 6 Mo F
CU-B408 Fecal 3 Mo M
CU-B433 Fecal 1 Yr F
CU-B463 Fecal 5 Mo M
CU-B478 Fecal 6 Mo F
CU-B486 Fecal 11 Mo F
CU-B500 Fecal 12 Yr M
CU-B579 Fecal 2 Mo F
CU-B580 Fecal 9 Mo F
CU-B587 Fecal 11 Mo M
CU-B588 Fecal 3 Mo F
CU-B595 Fecal 10 Mo F
CU-B596 Fecal 11 Mo M
CU-B606 Fecal NS NS
CU-B615 Fecal NS NS
CU-B628 Fecal 1 Yr F
CU-B636 Fecal 1 Yr M
CU-B685 Fecal 1 Yr F
CU-B688 Fecal 3 Mo M
CU-B705 Fecal 6 Mo M
CU-B711 Fecal 1 Yr M
CU-B806 Fecal 10 Mo F
CU-B811 Fecal 7 Mo M
CU-B812 Fecal 11 Mo M
CU-B825 Fecal 6 Mo F
CU-B846 Fecal 1 Yr M
CU-B847 Fecal 1 Yr F
CU-B850 Fecal 5 Mo M
CU-B851 Fecal 6 Mo M
CU-B852 Fecal 5 Mo M
CU-B865 Fecal 5 Mo M
CU-B867 Fecal 1 Yr F
CU-B868 Fecal 9 Mo M
CU-B869 Fecal 10 Mo M
CU-B874 Fecal 1 Yr F
CU-B903 Fecal 6 Mo M
CU-B961 Fecal 6 Mo M
CU-B984 Fecal 1 Yr M
CU-B1002 Fecal 1 Yr M
CU-B1009 Fecal 10 Mo F
CU-B1046 Fecal 1 Yr M
CU-B1050 Fecal 1 Yr M
CU-B1055 Fecal 9 Mo M
CU-B1064 Fecal 10 Mo M
CU-B1091 Fecal 8 Mo M
CU-B1154 Fecal 16 Yr F
CU-H403 NP sawab NS F
CU-H2107 NP sawab NS F
CU-H2108 NP sawab NS M
CU-H2159 NP sawab NS F
CU-H2779 NP sawab 49 Yr F
CU-C315 NP sawab 9 Mo F
CU-C534 NP sawab 2 Yr F
CU-C561 NP sawab 2 Yr F
CU-C724 NP sawab 7 Yr F
CU-C763 NP sawab 2 Yr M
CU-C936 NP sawab 1 Yr M
CU-C1204 NP sawab 3 Yr F
Abbreviation: Mo; Month, Yr; Year, NS; Not specify.
⁎ The new 3Dpol clade deﬁned in this study.replication cycle and thus contributing to antigenic drift with substi-
tution rates ranging from 2.2×10−3 to 2.8×10−3 have been shown
(Faria et al., 2009). Like with other picornaviruses, recombination in
their genome had been detected and the breaking point of recombina-
tion was shown at the junction between P1 and P2 and the 5′UTR and
P1 region (Benschop et al., 2008a, 2010; Drexler et al., 2011; Williams
et al., 2009; Zoll et al., 2009). The different clusters on the phylogenetic
tree of structural and non-structural genes have been clearly shown in a
previous study (Calvert et al., 2010) which pointed out that recombina-
tion had occurred; however, both process and effect of this event in
HPeV have remained unclear.Other virus HPeV type 3Dpol clade
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Fig. 1. Age distribution (A) and collection period of fecal (B) and NP swab (C) samples. The positive HPeV samples are shown as relative percentage of all samples collected.
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respiratory and fecal samples collected in different parts of Thailand from
Jan 2009–Jan 2011 by using RT-PCR to amplify the highly conserved re-
gion of the 5′UTR. Subsequently, the positive samples were further char-
acterized and the phylogenetic tree of the structural genes (VP3/VP1)
was constructed. Moreover, the recombination event of HPeV has also
been detected upon combined analysis of the phylogenetic trees of
both structural and non-structural genes.
Result
Study group and epidemiology of HPeV
A total of 3716 samples were sent for inﬂuenza virus (nasopha-
ryngeal swab) and Rota virus (stool specimens) detection (1868 fe-
males, 1833 males, and 15 with incomplete data as to their gender).
All samples had been collected during the period from 2009 to
2011. Of those, 2957 NP were from 2822 individual patients whose
age ranged 1 day to 90 years. All NP swabs were taken from patients
who presented with inﬂuenza like-illness in the out-patient depart-
ments of two different rural hospitals. An additional 759 fecal sam-
ples were taken from 715 different individuals aged between 1 day
and 24 years, who presented with acute diarrhea and sent for Rota
virus detection.
Routine screening for inﬂuenza and Rota virus was accomplished
by the in-house developed multiplex one-step real-time RT-PCR
using TaqMan probes (Suwannakarn et al., 2008) and one-step RT-
PCR (Theamboonlers et al., 2002), respectively. Glyceraldehyde 3-
phosphate dehydrogenase (GADPH), the human housekeeping gene,
served as an indicator for successful RNA extraction and subsequent-
ly, as an RT reaction control. This gene could be ampliﬁed in all sam-
ples (data not shown). Screening NP samples for inﬂuenza virus
showed 25(0.9%) samples positive for inﬂuenza B virus, 343 samples
(11.6%) positive for inﬂuenza A virus 2009 pandemic strain subtype
H1, 115 samples (3.9%) were positive for inﬂuenza A virus subtype
H3, and 32 samples were positive for inﬂuenza A virus whose subtype
could not be classiﬁed (1.1%). Rota virus was detected in 348 fecal
samples (45.9%).
Screening for HPeV was performed by using a very sensitive
nested RT-PCR with the primer pair sequences retrieved from the
highly conserved region of the 5′UTR for all HPeV types (Harvala et
al., 2008). HPeV was thus detected in 58 out of altogether 3716 sam-
ples (1.6%) of which 46 samples were fecal samples (6.1% of fecal
samples) and 12 samples were NP swab samples (0.4% of NP swab
samples). The details of these 58 samples are shown in Table 1. The
rate of HPeV detection did not differ between males and females.
Moreover, simultaneous infection with Rota virus was detected in
16 fecal samples accounting for 34.8% of the positive stools
(Table 1). One NP swab sample showed simultaneous infection with
inﬂuenza A virus subtype H3 and HPeV (Table 1). The age of patients
diagnosed with HPeV infection in this study ranged from 2 months to
49 years (Table 1.) however, infection was most prevalent among in-
fants between 3 months and 1 year of age (Fig. 1A).
Typing of HPeV
For typing, all samples positive for the 5′UTR of HPeV were sub-
jected to partial ampliﬁcation of VP3/VP1 by using a highly sensitive
one-step nested RT-PCRmethod which had proven successful for typ-
ing as described previously (Calvert et al., 2010). All 58 samples pos-
itive for the 5′UTR were subsequently subjected to direct sequencing.Fig. 2. Phylogenetic tree of partial VP3/VP1 (A) and 3Dpol gene (B). Each branch was labe
colors represent the different HPeV genotypes which were classiﬁed based on the cluster o
cated as red letters on each branch of the tree. Only the bootstrap with over 70 were shown
collapsed and shown as the black triangle in the tree.The phylogenetic tree shown in Fig. 2A demonstrates that the strains
detected could be identiﬁed as HPeV 1A in three samples and as
HPeV1B in 27 samples. Of those 27, one sample (CU-B628) was highly
divergent from the rest of the group and clustered in its own clade
(Fig. 2A). The divergence of CU-B628 amounted to 24% upon compar-
ison with the Harris strain and to 18% when compared with the
remaining HPeV1B clade. Furthermore, 5 samples could be identiﬁed
as HPeV2; 1 sample as HPeV3; 2 samples as HPeV4; 2 samples as
HPeV5; 15 samples as HPeV6; 1 sample as HPeV10 and 2 samples as
HPeV14 (Table 1). All strains investigated in this study showed the
majority clustered with the previously published sequences from
Thailand (Fig. 2A).
The virus types identiﬁed from fecal samples were highly diverse
and included HPeV1A, HPeV1B, HPeV2, HPeV3, HPeV4, HPeV5,
HPeV6, and HPeV14 (Table 1 and Fig. 1B). In contrast, virus genotypes
isolated from NP swab samples showed less diversity. The ﬁve geno-
types identiﬁed were HPeV1A, HPeV1B, HPeV4, HPeV6 and HPeV10
(Table 1 and Fig. 1C).
In this study, the majority of patients infected with HPeV were
under 2 years of age. The most predominant genotype identiﬁed
from this study, HPeV1B, was detected in patients below the age of
2 years except for one sample obtained from a 16-year-old girl
(Table 1 and Fig. 1A). In contrast, HPeV6 was detected in a slightly
higher age group when compared with HPeV1B. However, this dif-
ference between age groups was not statistically signiﬁcant
(p value=0.302 with α level=0.05). HPeV6 was predominantly
detected in children between 7 months and 5 years of age (Table 1
and Fig. 1A). Interestingly, one fecal sample collected from a 49-
year-old patient was positive for HPeV6 (Table 1 and Fig. 1A). The
new types, HPeV10 and HPeV14, were identiﬁed in one NP swab sam-
ple taken from a 7-year-old girl and two fecal samples taken from two
boys aged 6 months and 8 months, respectively (Fig. 1A and Table 1).
HPeV1A and HPeV2 could be identiﬁed in two patient age groups,
which were 3–6 months and 1–2 years (Fig. 1A). HPeV3, HPeV4 and
HPeV5, had been isolated from patients of 1–2 years, 3–6 months,
and 7–12 months of age, respectively (Fig. 1A and Table 1).
HPeV monthly distribution in fecal samples and NP swab is shown
in Fig. 1B and C, respectively. HPeV1A could be isolated in February
and May 2010 from fecal samples and July 2010 from NP swab sam-
ples (Fig. 1B and C). HPeV1B distribution in fecal samples does not
seem restricted to a speciﬁc timeframe because it could be detected
throughout the study period (Fig. 1B). On the other hand, in NP
swab samples, HPeV1B could be detected during the ﬁrst half of the
study period and was then substituted by HPeV6 (Fig. 1C). HPeV2
could only be detected in stool and for a short time during the
study period (July–August 2010). One strain identiﬁed as HPeV3
was isolated from a fecal sample collected in December 2009
(Fig. 1B). HPeV4 was detected in a fecal sample collected in January
2010 and an NP swab sample collected in July 2010 (Fig. 1B and C).
Interestingly, HPeV5 was only detected at the very beginning of the
study (January and March 2009) and subsequently disappeared
(Fig. 1B). The new types, HPeV10 and HPeV14, were detected in
March 2010 (Fig. 1C) and February 2011(Fig. 1B), respectively.
VP1 divergence
The substitution rate in the partial VP3/VP1 gene of all HPeV
genotypes was 3.02×10−3 nucleotides per site per year (with
2.29×10−3–3.83×10−3 as highest posterior density; HPD, interval).
Information on virus sequences of genotypes 1A, 2, 4, 5, and 7–16
is limited. Therefore, the nucleotide change rate could only beled as genotype/3D clade/strain name/year of collection/origin country. The different
n the phylogenetic tree of the VP3/VP1 gene (A). The samples from this study are indi-
in phylogenetic tree and the large clades that the study samples did not appeared were
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result shown in Table 2 indicates that these three genotypes were in a
neutral selection condition based on the ratio of non-synonymous
change per site to synonymous change per site (dN/dS). In this study,
the substitution rate of HPeV1B amounted to 9.11×10−3 substitutions
per site per year exceeding by more than 3 times that of HPeV3 and by
nearly 2 times that of HPeV6 with 3.03×10−3 and 5.10×10−3, respec-
tively (Table 2).
Recombination event of HPeV
Together with the structural gene, the non-structural 3D gene at
the 3′end of the virus genome responsible for RdRp activity was
used to investigate the recombination event (Calvert et al., 2010).
The speciﬁc 3D gene primer sets were incorporated into a one-step
nested RT-PCR method described elsewhere (Calvert et al., 2010).
All HPeV positive samples with successful ampliﬁcation of the 5′UTR
and VP3/VP1 were also subjected to this 3D ampliﬁcation and direct
sequencing. The phylogenetic tree of the 3D gene is shown in
Fig. 2B and the speciﬁc clade assigned for each HPeV positive sample
is shown in Table 1. Interestingly, the high divergence rate ranged
from 6.2% to 16.1% when compared with the nearest clade on the
phylogenetic tree of 3Dpol gene was shown in sixteen strains of vi-
ruses identiﬁed in this study (Supplement Table S2). As deﬁned in a
previous study, the 5.5% divergence from each other was shown as
the cut off for a different 3Dpol gene clade assignment (Calvert et
al., 2010). Therefore, based on this demarcation, we could identify 6
additional 3Dpol clades. The samples identiﬁed in newly assigned
clades of 3Dpol are shown in Table 1 and Fig. 2B. For recombination
analysis, the discordant grouping based on the 3Dpol gene of the geno-
type characterized by theVP3/VP1 genephylogeny is indicative of recom-
bination (Calvert et al., 2010). Therefore, in this study recombinationwas
detected in 16 samples including 3 strains of HPeV1A (CU-B711, CU-B825
and CU-H2107); 7 of HPeV1B (CU-B433, CU-B615, CU-B688, CU-B806,
CU-B846, CU-B851, and CU-B1002); 2 of HPeV4 (CU-B705 and CU-
H2018); 1 of HPeV5 (CU-B606); 1 of HPeV6 (CU-B984) and 2 of
HPeV14 (CU-B961 and CU-B1091). The most frequently recombination
event was shown in HPeV1B in which could be classiﬁed into 3 clades
of 3Dpol including BA, AE′ and W (Table 1). The 3Dpol clades that were
assigned to the remaining recombination strains are shown in Table 1.
The recombination detection rate is 27.6%, this may be underlining the
detection rates which based on samples and children.
Discussion
Molecular epidemiology
Until recently, based on their genomic sequences, 16 genotypes of
virus have been discovered and subsequent studies have shown that
the different genotypes of virus cloud provide the different diseases,
for example, HPeV1 is associated with diseases of the GI tract and
HPeV3 is closely related with sepsis and encephalitis in neonates
(Abed and Boivin, 2006; Boivin et al., 2005; Harvala et al., 2009). Ep-
idemiology of HPeV is required to further our understanding of dis-
ease causation and possibly, geographic distribution of the virus.
Recently, molecular techniques were used for detection and geno-
type classiﬁcation. For screening, nested RT-PCR with a primer pairTable 2
Estimate of sequence rate change of HPeV1B, 3, and 6.
HPeV type Distance⁎ dN/dS⁎ Substitution rate (×10−3) MRCA
1B 0.1000 0.0099 9.11 (5.14–13.36) 1985 (1978–1991)
3 0.0346 0.0181 3.03 (1.57–4.49) 1990 (1985–1995)
6 0.0607 0.0334 5.10 (2.32–8.24) 1994 (1987–1999)
⁎ Calculated by using maximum composite likelihood as the substitution model.speciﬁc for the conserved region of the 5′UTR was applied. The result
showed that 1.6% of samples (58 of 3716 samples) were positive for
HPeV with more than one third originating from the GI tract
(feces=46; 6.1%, NP swab=12; 0.4%) (Table 1). The percentage of
positive samples in this study was lower than in the previous report,
1.2% of respiratory samples (Harvala et al., 2008) and 16.3% of fecal
samples (Benschop et al., 2008b). However, the molecular epidemiol-
ogy data presented in this study was based on the number of samples
rather than the number of patients whichmight account for the lower
detection rate. The difference in virus detection rate may well be due
to the speciﬁc year of sample collection and geographic location. In-
terestingly, the study of Pham et al. conducted in 2010 which includ-
ed stool samples negative for human rotavirus from the northern part
of Thailand showed 14.6% positive for HPeV. In another way, if the
positive samples of human rotavirus were excluded in this study,
the percentage of HPeV positive (11.2%) stool samples has shown a
similar range as the study of Pham et al. in 2010.
As reported by previous studies, the majority of HPeV positive
samples originated from patients below the age of 2 years with
the highest rate shown among 3 month-to-1-year olds (Fig. 1A).
HPeV1B is the most prevalent genotype in samples collected from
children, whereas HPeV6 seems to infect older patients (Fig. 1A).
However, a larger number of samples positive for other genotypes
should be considered for future analysis to further our understanding
of age distribution for this virus. Interestingly, in this study, HPeV was
detected in three patients above 10 years of age. It is unusual to detect
HPeV in adults but a few studies have reported HPeV detection in
over 10-year-olds (Abed and Boivin, 2006; Figueroa et al., 1989; Li
et al., 2009; Tapia et al., 2008). Therefore, this provides additional ev-
idence of HPeV infection in patients above the age of 10 years. Unfor-
tunately, since the samples included in this study were anonymous,
further information on these three patients as for example, any un-
derlying disease could not be obtained. (Table 1).
The cycle of HPeV infection, occurring twice per year, in summer
(April to June) and winter (December to February), has been shown
in this study (Fig. 1B and C). The same seasonal occurrence of HPeV
infection has been reported by Harvala et al. (2008) in Scotland. In
our study had identiﬁed the only one sample that deﬁned as
HPeV3 during the winter season. As same as previously reported,
HPeV3 could be identiﬁed in the winter season (Abed and Boivin,
2006; Harvala et al., 2009). However, the HPeV3 was detected during
the summer season had also been reported (Benschop et al., 2006b).
In this study, two types of HPeV, HPeV1 and HPeV6, were predomi-
nant in respiratory samples. This is in agreement with the data pre-
sented by Havala et al. in 2008 (Fig. 1C). In contrast, in fecal
samples, only HPeV1B was predominant and spread throughout the
study period (Fig. 1B). In addition, HPeV2 was frequently identiﬁed
in our study, while this type of virus has not been detected in any
other recent study (Benschop et al., 2008b; Harvala et al., 2008).Addi-
tional epidemiology studies might provide further understanding of
unusual or new types of HPeV.
Typing, recombination and evolution of HPeV
Based on the phylogeny of the VP3/VP1 gene, a profound diversity
of HPeV genotypes was found in this study with the eight genotypes
1A, 1B, 2, 3, 4, 5, 6 and two newly recently identiﬁed genotypes, 10
and 14, classiﬁed (Fig. 2A). Genotype 1B was predominant and upon
comparison between the 6 different lineages as showed multiple var-
iations in Fig. 2A. Interestingly, CU-B628 was separate in its own clade
on the phylogenic tree of the VP3/VP1 gene and the divergence was
equal to 24% when compared with the Harris strain. Since the diver-
gence for new genotype assignment has to exceed 25%, unfortunately,
this CU-B628 had still been assigned to genotype 1B. Although these
characteristics are insufﬁcient to assign a new genotype to this strain,
its variety should be addressed. The viruses identiﬁed from this study
165T. Chieochansin et al. / Virology 421 (2011) 159–166were grouped together on the phylogenetic tree of VP3/VP1 gene and
also clustered with viruses previously reported from Thailand
(Fig. 2A). This indicates a geographically speciﬁc common determi-
nant that appears to be found on this VP3/VP1 phylogenetic tree of
HPeV. Moreover, difference of the HPeV genotype could be detected
in children below 2 years of age.
Altogether, the genotypes have not evolved quite as rapidly as the
substitution rate calculated by BEAST suggested (3.02×10−3 substi-
tutions per site per year) which was slightly higher than that previ-
ously proposed for the VP1 gene (Faria et al., 2009). However, along
with phylogenetic analysis, a vast difference in substitution rate was
shown among different genotypes of virus (Table 2). Incorporation
of much more samples used for the calculation may be the reason
why the evolution rate in this study appeared slightly higher than
that previously estimated (Calvert et al., 2010). Similarly, the dN/dS
calculated from this study also were slightly higher than previously
mentioned by Calvert et al. (2010). In contrast, the MRCA shown in
our study (Table 2.) did not show any difference to the previous re-
port (Calvert et al., 2010). Further studies on larger sample sizes
will provide further understanding of virus evolution.
Interestingly, as deﬁned in the previous study, more than 5.5% di-
vergence was shown as the cut off for a different 3Dpol gene clade as-
signment (Calvert et al., 2010). Hence 6 additional new 3Dpol clades
could be deﬁned based on our study samples (Table 1.).
Recombination of HPeV had previously been addressed with the re-
combination breaking points established at the junction between 5′UTR
and P1 and the P1 and P2 polyprotein (Benschop et al., 2008a, 2010;
Drexler et al., 2011; Williams et al., 2009; Zoll et al., 2009). Despite the
phylogenetic analysis comparison between structural and non-structur-
al genes such as the 3Dpol gene was successfully used to investigate re-
combination (Calvert et al., 2010). The discordance cluster in the 3Dpol
gene when compared with the VP3/VP1 gene phylogenetic tree proves
that recombination in the virus genome has occurred (Calvert et al.,
2010). Most of the samples from our study were classiﬁed as the same
clade for 3Dpol phylogenetic tree as the reported in Thai samples that
reported by Calvert et al. (2010) (Table 1). Sixteen samples (27.6%)
showed discordance between two genetic regions on the phylogenetic
tree (Fig. 2) serving as evidence for recombination from this study.
HPeV1B was the predominant genotype with a recombination frequen-
cy of 27%. This study was in agreement with previous research empha-
sizing the high recombination frequency of HPeV type 1B (Calvert et
al., 2010). In contrast, HPeV6 exhibited less recombination frequency
(6%)with only one sample identiﬁed (CU-B984, Fig. 2.). Other genotypes
including HPeV1A, HPeV4, HPeV5, and HPeV14 had also
undergone recombination (Fig. 2.), however, the frequency of recombi-
nation had not been done due to the small identiﬁcation numbers from
the study. HPeV3 isolated from this study clustered in the correlated
phylogenetic tree cladewith both VP3/VP1 and 3Dpol geneswhen com-
pared to the previous report (Fig. 2.) (Calvert et al., 2010). Therefore, the
recombinationmight not have been detectable in this study. The under-
lying factors ormechanisms for the recombination event are still unclear
and should be addressed by further investigation.
In conclusion, although HPeV has been discovered a long time ago,
its biology, epidemiology, evolution and pathogenicity are still
unclear. Therefore, ongoing molecular research will further our un-




The nasopharyngeal (NP) swabs were collected from patients pre-
senting with inﬂuenza-like illness. A total of 2957 of NP swab samples
were collected between July 14, 2009 and March 9, 2011. All samples
were sent from local hospitals including; 1703 samples fromChumphaehospital, Chumphae district, Khonkaen province, 1254 samples from
Thungsong hospital, Thungsong district, Nakorn Sri Thammarat prov-
ince. Samples were kept in transport media which contain phosphate-
buffered saline (PBS) with antibiotics (2×106 U/l of penicillin G and
200 mg/l of streptomycin). All were kept on ice then sent to Center of
Excellence in Clinical Virology, Department of Pediatrics, Faculty of
Medicine, Chulalongkorn University for the routine screening. Samples
were processed immediately upon arrival, the remaining were kept
at−70 °C for further use.
Fecal samples were sent to our center for Human Rota virus rou-
tine screening. A total of 715 fecal samples had been collected in
the 2-year period of January 7, 2009 to April 18, 2011. Of those, 12
samples were sent from Umphang hospital, Umphang district, Tak
province; 597 samples from Chumphae hospital, Chumphae district,
Khonkaen province and 150 samples from King Chulalongkorn Me-
morial hospital, Bangkok. Upon arrival, fecal samples were diluted
1:10 with PBS, thoroughly mixed on a vortex and centrifuged at
8000 rpm. Supernatants were collected and stored at −70 °C until
further use.
RNA extraction and HPeV detection
All samples were subjected to RNA extraction by conventional
GTC-phenol-chloroform method performed on 200 μl each of clinical
samples. The extracted RNA was stored at −70 °C until used.
All extracted RNA was subjected to reverse transcription into
cDNA using the ImProm-II™ Reverse Transcription system (Promega,
Madison, WI). Reverse transcription (RT) was performed by following
the manufacturer's speciﬁcations and a random hexamer primer was
used for the RT step. cDNA was stored at −20 °C until used.
Nested-PCR for HPeV detection was modiﬁed from a previous
study (Harvala et al., 2010). The PerfectTaq Plus MasterMix (5
PRIME, Darmstadt, Germany) was used as the ampliﬁcation mixture.
The predicted positive result was shown as a single band of 243 bp
when visualized under UV light after 2% agarose gel electrophoresis
and staining with ethidium bromine.
Partial VP3/VP1 and 3Dpol gene ampliﬁcation
For HPeV characterization, the samples positive for the 5′UTRwere
subjected to nested PCR to amplify the VP3/VP1 junction for HPeV typ-
ing as previously described (Harvala et al., 2010). The expected PCR
product was 304 bp when virtualized under UV light after 2% agarose
gel electrophoresis and staining with ethidium bromine.
The partial 3Dpol gene was ampliﬁed by nested PCR modiﬁed
from a previous report (Calvert et al., 2010). The expected second
round PCR product of 700 bp was virtualized under UV light after
2% agarose gel electrophoresis and staining with ethidium bromine.
All VP3/VP1 and 3Dpol positive amplicons were puriﬁed by using
Agarose Gelextract Mini Kit (5 PRIME, Darmstadt, Germany). Direct
sequencing was performed under 1st BASE DNA Sequencing Services
(1st BASE Laboratories, Malaysia). Sequencing results were annotat-
ed, aligned, and managed by using combination of software including
Basic Local Alignment Search Tool (BLAST) (http://blast.ncbi.nlm.nih.
gov/Blast.cgi), Simmonics version 1.7 (www.virus-evolution.org),
Chromas Lite (http://www.technelysium.com.au/chromas_lite.html),
and BioEdit version 7.0.4.1(Hall, 1999).
Molecular and evolution analysis
All study sequences had been submitted to GenBank data base.
The accession number that included in this study was show in Sup-
plement Table (S1). Phylogenetic trees were constructed by using
MEGA 4 software (Tamura et al., 2007) in which neighbor-joining
method with 1000 replication for bootstrapping was implemented.
Trees contracted under maximum-composite-likelihood (MCL) as
166 T. Chieochansin et al. / Virology 421 (2011) 159–166distances model and using pairwise deletion as gap/missing data pro-
cessing. The nucleotide substitution rate and most recently common
ancestor (MRCA) were achieved by using Bayesian Evolutionary Anal-
ysis by Sampling Trees (BEAST) software version 1.6 (Drummond and
Rambaut, 2007). The relaxed clock-uncorrelated exponential with
10 million chains was run under GTR with gamma distribution substi-
tution model. The data from BEAST were analyzed by TACER program
(http://beast.bio.ed.ac.uk/Tacer).
Ethical consideration
All samples that were included in this study were sent for routine
diagnosis in our center. The personal data such as name and HN did
not appear in any part of the document in this study. All samples
were taken with permission from the Director of Chulalongkorn
King Memorial hospital. Moreover, the study was conducted after
the approval of the Ethics Committee of the Faculty of Medicines,
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Supplementary materials related to this article can be found on-
line at doi:10.1016/j.virol.2011.09.021.
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